Israel - English - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - film coated tablets - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations - - oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who choose to use an oral contraceptive as their method of birth control.- treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. - in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.

Israel - English - Ministry of Health

bayer israel ltd - dienogest - tablets - dienogest 2 mg - dienogest and estrogen - dienogest and estrogen - treatment of endometriosis.

Israel - English - Ministry of Health

bayer israel ltd - mesterolone - tablets - mesterolone 25 mg - mesterolone - mesterolone - androgen therapy. androgen deficiency or male infertility when associated with primary or secondary male hypogonadism.

Israel - English - Ministry of Health

bayer israel ltd - cyproterone acetate - tablets - cyproterone acetate 10 mg - cyproterone - cyproterone - treatment of pronounced signs of virilisation in women, which make hormone therapy necessary:• severe forms of acne, when it is accompanied by inflammation and the formation of nodes (acne papulopustulosa, acne nodulocystica) or if there is a risk of scarring,• moderate to severe forms of hirsutism,• moderate to severe forms of androgenic alopecia.cyproterone acetate 10 mg is indicated for pronounced signes of virilisation in women, which make hormone therapy necessary if satisfactory results could not be obtained with medicinal products containing low-dose cyproterone or with other treatment options. when treating acne, hormone treatment should be weighed against systemic antibiotic treatment

Israel - English - Ministry of Health

bayer israel ltd - cyproterone acetate; ethinylestradiol - tablets - ethinylestradiol 35 mcg; cyproterone acetate 2 mg - cyproterone and estrogen - cyproterone and estrogen - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - dienogest, micronized - tablet - 2.0 mg - dienogest, micronized 2.0 mg

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - drospirenone; ethinylestradiol - tablet, film coated - 3 mg - drospirenone 3 mg; ethinylestradiol 0.03 mg

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - norethisterone - tablet - 5 mg - norethisterone 5 mg

Israel - English - Ministry of Health

bayer israel ltd - norethisterone acetate - tablets - norethisterone acetate 5 mg - norethisterone - norethisterone - oral progestron for: dysfunctional bleeding, primary and secondary amenorrhea, premenstrual syndrome, timing of mensturation and endometriosis.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bayer weimar gmbh & co. kg - pink tablet-drospirenone, ethinyl estradiol, levomefolate (levomefolate calcium); light orange tablet-levomefolate (levomefolate calcium) - tablets film-coated - pink tablet-3mg+ 0,02mg+ 0,451mg